These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15506481)

  • 1. [Urotensin II: biological action on the kidney].
    Satoh F; Ito S
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():719-21. PubMed ID: 15506481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Possible involvement of urotensin II in essential hypertension].
    Ikeda K; Tojo K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():727-9. PubMed ID: 15506483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Discovery and clinical implications of urotensin II].
    Naruse M; Nagata D; Tanabe A; Imaki T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():685-93. PubMed ID: 15506473
    [No Abstract]   [Full Text] [Related]  

  • 4. Urotensin II is a nitric oxide-dependent vasodilator and natriuretic peptide in the rat kidney.
    Zhang AY; Chen YF; Zhang DX; Yi FX; Qi J; Andrade-Gordon P; de Garavilla L; Li PL; Zou AP
    Am J Physiol Renal Physiol; 2003 Oct; 285(4):F792-8. PubMed ID: 12783779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urotensin II and cardiac disease].
    Nishikimi T
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():722-6. PubMed ID: 15506482
    [No Abstract]   [Full Text] [Related]  

  • 6. [Autocrine/paracrine role of urotensin II as a growth factor].
    Yoshimoto T; Hirata Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():711-4. PubMed ID: 15506479
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vasoconstrictive action of urotensin II].
    Ikeda K; Tojo K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():709-10. PubMed ID: 15506478
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nitric oxide (NO) and normal and pathologic renal development].
    Simeoni U; Helwig JJ
    Pediatr Med Chir; 1997; 19(5):313-5. PubMed ID: 9493221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factor.
    Yoshimoto T; Matsushita M; Hirata Y
    Peptides; 2004 Oct; 25(10):1775-81. PubMed ID: 15476945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of urotensin-II in cardiovascular disease.
    Russell FD
    Pharmacol Ther; 2004 Sep; 103(3):223-43. PubMed ID: 15464591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A vasoactive peptide: urotensin II].
    Liu GQ; Zeng ZP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):525-8. PubMed ID: 16178453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tissue distribution and secretory regulation of urotensin].
    Tojo K; Ikeda K
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():702-4. PubMed ID: 15506476
    [No Abstract]   [Full Text] [Related]  

  • 13. Urotensin II: lessons from comparative studies for general endocrinology.
    Lu W; Abdel-Razik AE; Ashton N; Balment RJ
    Gen Comp Endocrinol; 2008 May; 157(1):14-20. PubMed ID: 18440535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular contractile effect of urotensin II in young and aged rats: influence of aging and contribution of endothelial nitric oxide.
    Ishihata A; Sakai M; Katano Y
    Peptides; 2006 Jan; 27(1):80-6. PubMed ID: 16159683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urotensin-II as a novel therapeutic target in the clinical management of cardiorenal disease.
    Gilbert RE; Douglas SA; Krum H
    Curr Opin Investig Drugs; 2004 Mar; 5(3):276-82. PubMed ID: 15083593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urotensin II: its function in health and its role in disease.
    Ong KL; Lam KS; Cheung BM
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):65-75. PubMed ID: 15883758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Overview of clinical applications of urotensin II].
    Imaki T; Tanabe A; Naruse M
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():730-4. PubMed ID: 15506484
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal haemodynamic and tubular actions of urotensin II in the rat.
    Abdel-Razik AE; Forty EJ; Balment RJ; Ashton N
    J Endocrinol; 2008 Sep; 198(3):617-24. PubMed ID: 18577565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urotension II and renal disease: protective or causal role?].
    Spoto B
    G Ital Nefrol; 2008; 25(5):513. PubMed ID: 18828113
    [No Abstract]   [Full Text] [Related]  

  • 20. Urotensin II: the old kid in town.
    Onan D; Hannan RD; Thomas WG
    Trends Endocrinol Metab; 2004; 15(4):175-82. PubMed ID: 15109617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.